Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Abbott takes an ax to sales forecast as COVID testing dries up faster than expected
HHS launches $50M venture capital partnership to develop tech for pandemic response
Government relief, summer volume spikes kept primary physicians afloat in 2020: MGMA report
Pandemic's spotlight on pharma resurfaces longstanding contradictions: report
UPDATED Coronavirus tracker: Employers' vaccine requirements legal, federal commission says
COVID-19 tracker: WHO backs Sinovac vaccine; Denmark reconsiders AstraZeneca, J&J vaccine hold

Featured Story

Abbott takes an ax to sales forecast as COVID testing dries up faster than expected

By Conor Hale

The peak for COVID-19 testing may have thoroughly passed—judging by Abbott's new sales projections, at least. The testing giant now projects steeper-than-expected declines in diagnostic testing as vaccination rates climb, and it's not only slashed its sales forecast by as much as $2 billion, but also cut its spending plans for the rest of the year.

HHS launches $50M venture capital partnership to develop tech for pandemic response

By Heather Landi

The federal government wants to tap into venture capital approaches to help bring to market breakthrough technologies in preparation for the next pandemic. BARDA Ventures, the venture arm of the Biomedical Advanced Research and Development Authority, is partnering with a nonprofit to invest a minimum of $50 million over five years with the potential for up to $500 million over 10 years to commercialize new tech and medical products.

Government relief, summer volume spikes kept primary physicians afloat in 2020: MGMA report

By Jacqueline Renfrow

Despite the pandemic, physician compensation remained steady in 2020, with a modest increase in compensation for primary care physicians and a slight increase for specialty physicians.

Pandemic's spotlight on pharma resurfaces longstanding contradictions: report

By Beth Snyder Bulik

Thanks to the pandemic, everyone is looking at the pharma industry again—but what many are seeing are the same old contradictions. Along with new appreciation for the industry and its quick pandemic response comes a less favorable spotlight on longstanding problems around pricing, access and the complex U.S. healthcare system, a new report finds.

UPDATED Coronavirus tracker: Employers' vaccine requirements legal, federal commission says

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

COVID-19 tracker: WHO backs Sinovac vaccine; Denmark reconsiders AstraZeneca, J&J vaccine hold

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

The World Health Organization authorized the vaccine from China's Sinovac, paving the way for its deployment in poorer nations. Denmark is reconsidering its decision to exclude the shots from Johnson & Johnson & AstraZeneca in its vaccination program. And more headlines.

COVID-19 Tracker